Researchers

Working with BioCurate

Hear from Professor Roger Daly from the Monash Biomedicine Discovery Institute on how his team is working with BioCurate to translate their discovery into a novel treatment for breast cancer.

Click here to find out more about researchers currently working with BioCurate and how you can get involved

Process

BioCurate has a formal, rigorous process for project review and investment decision-making that takes advantage of international industry contacts, ‘in-house’ expertise, and specialist consultants, while maintaining ongoing and effective two-way communication with researchers and University Innovation teams.

The review process involves pipeline review and project screening, meetings with the investigators and technology transfer representatives, due diligence and review of development plans and commercial strategy, preparation of project investment proposals for Investment Committee review and recommendation to the Board for approval.

• Initial screening – Projects are submitted to BioCurate and are reviewed for scientific & medical soundness from a commercial perspective. Feedback is provided to researchers to further understand the potential for impact (e.g. does their project address an unmet need?) and risk (e.g. do they have a validated target?)
• Proof of Concept (POC) Fund – This Fund specifically supports early-stage opportunities where preliminary data may not be comprehensive, but supportive of the target and approach. Following due diligence, the Fund will assist with additional experimental validation to address identified developmental gaps and explore commercialisation pathways.

Linkages

BioCurate has developed a number of linkages with key global biopharmaceutical companies. This is in addition to the established networks individual staff members have brought to the Company. These partnerships provide valuable advice and insight which can help guide research, giving projects the best opportunity to progress in the translation process and a potential investment pathway. Having access to such a breadth and depth of international talent is unique and unprecedented in Australia and is a resource that researchers are able to tap into via BioCurate.

For more information, visit our Industry Partners and Sector Partners pages.

Specialist Skills

With decades of scientific and commercial experience, BioCurate’s team have conducted best-practice drug development and translation across multiple geographies and therapeutic areas in both smaller start-ups and global biopharmaceutical companies.

Our team has worked across disease areas such as oncology, neurobiology, dermatology, cardiovascular disease, immune oncology, respiratory and more dermatology in Australia, Asia, Europe and North America, and has first-hand experience of the translation journey from discovery to approval. These skills go beyond the scientific, with members of the BioCurate team possessing expertise in clinical development, medical affairs, marketing authorisation, and intellectual property (IP) and lifecycle management.

We are here to help, provide advice and insight, and foster collaborations between you and potential industry partners.

For more information, visit Our Team page.